Neurocrine Biosciences | Crediti Commerciali



Trade Debtors Cambiamento Data
AbbVie USD 12.48B 1.56B 2025-03
Acadia Pharmaceuticals USD 119.69M 5.97M 2025-06
Agios Pharmaceuticals USD 4.99M 1.64M 2025-06
ALKERMES USD 356.33M 34.58M 2025-06
Alnylam Pharmaceuticals USD 567.11M 149.08M 2025-06
Amgen USD 8.7B 569M 2025-06
Biogen USD 2.08B 87.5M 2025-06
BioMarin Pharmaceutical USD 855.85M 116.68M 2025-06
Cytokinetics USD 2.01M 14.64M 2025-03
Dynavax Technologies USD 73.34M 16.79M 2025-06
Exelixis USD 292.35M 10.72M 2025-07
Gilead Sciences USD 4.78B 393M 2025-06
Halozyme Therapeutics USD 316.34M 11.72M 2025-06
Incyte USD 842.89M 19.76M 2025-06
Ionis Pharmaceuticals USD 52.58M 12.87M 2025-06
Neurocrine Biosciences USD 595.7M 79.7M 2025-06
Pfizer USD 16.09B 1.35B 2025-06
Prothena USD 0 0 2024-12
Regeneron Pharmaceuticals USD 5.61B 49M 2025-06
Repligen USD 147.41M 13.3M 2025-03
Sarepta Therapeutics USD 609.6M 114.93M 2025-06
Teva Pharmaceutical Industries USD 3.56B 180M 2025-06
Ultragenyx Pharmaceutical USD 124.46M 25.62M 2025-06
Vertex Pharmaceuticals USD 1.89B 88.4M 2025-06


Neurocrine Biosciences Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.